Clinical Trial Update: Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

View source ↗

Summary

This is a completed clinical trial update examining the incidence, prevalence, and symptom burden of advanced renal cell carcinoma in a commercially insured pop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Carcinoma, Renal Cell | Status: COMPLETED